Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wunderlich

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 13, 2013
Novel ROS-activated agents utilize a tethered amine to selectively target acute myeloid leukemiaTiffany R Bell-Horwath, Anish K Vadukoot, Fathima Shazna Thowfeik, et al.
Blood Advances|December 20, 2024
Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemiaShan Lin, Michael Kotliar, Sushmitha Vallabh, et al.
Bioorganic & Medicinal Chemistry|December 4, 2014
Design of a hydrogen peroxide-activatable agent that specifically targets cancer cellsAnish K Vadukoot, Safnas F AbdulSalam, Mark Wunderlich, et al.
Plos One|November 21, 2019
Improved chemotherapy modeling with RAG-based immune deficient miceMark Wunderlich, Nicole Manning, Christina Sexton, et al.
Frontiers in Oncology|April 30, 2021
PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic LeukemiaMark Wunderlich, Nicole Manning, Christina Sexton, et al.
Chembiochem : a European Journal of Chemical Biology|October 1, 2015
A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway CompoundsFathima Shazna Thowfeik, Safnas F AbdulSalam, Mark Wunderlich, et al.
Blood Advances|February 25, 2020
High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapyLynn H Lee, Christa Krupski, Jason Clark, et al.
Leukemia|July 1, 2018
A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cellsWei Du, Wei Liu, Benjamin Mizukawa, et al.
Autophagy|March 11, 2017
Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquineXiaoyi Chen, Jason Clark, Mark Wunderlich, et al.
Nature Communications|October 25, 2024
Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosisAshley E Culver-Cochran, Aishlin Hassan, Kathleen Hueneman, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|April 13, 2013
Novel ROS-activated agents utilize a tethered amine to selectively target acute myeloid leukemiaTiffany R Bell-Horwath, Anish K Vadukoot, Fathima Shazna Thowfeik, et al.
Blood Advances|December 20, 2024
Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemiaShan Lin, Michael Kotliar, Sushmitha Vallabh, et al.
Bioorganic & Medicinal Chemistry|December 4, 2014
Design of a hydrogen peroxide-activatable agent that specifically targets cancer cellsAnish K Vadukoot, Safnas F AbdulSalam, Mark Wunderlich, et al.
Plos One|November 21, 2019
Improved chemotherapy modeling with RAG-based immune deficient miceMark Wunderlich, Nicole Manning, Christina Sexton, et al.
Frontiers in Oncology|April 30, 2021
PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic LeukemiaMark Wunderlich, Nicole Manning, Christina Sexton, et al.
Chembiochem : a European Journal of Chemical Biology|October 1, 2015
A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway CompoundsFathima Shazna Thowfeik, Safnas F AbdulSalam, Mark Wunderlich, et al.
Blood Advances|February 25, 2020
High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapyLynn H Lee, Christa Krupski, Jason Clark, et al.
Leukemia|July 1, 2018
A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cellsWei Du, Wei Liu, Benjamin Mizukawa, et al.
Autophagy|March 11, 2017
Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquineXiaoyi Chen, Jason Clark, Mark Wunderlich, et al.
Nature Communications|October 25, 2024
Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosisAshley E Culver-Cochran, Aishlin Hassan, Kathleen Hueneman, et al.
Pageof 12